Skip to content Skip to navigation menu

uvex quatro pro safety shoes S3 SRC

uvex quatro pro safety shoes S3 SRC

Uvex

Non metallic Quatro safety shoe with exceptional grip and comfort. Sizes: 6-12.

Code: 652340


Uvex

£71.15 Pair (ex. VAT)

£85.38 inc. VAT
Quantity discounts
£68.99 10+ (save £21.60+)
- +

uvex quatro pro safety shoes S3 SRC

Sturdy modern shoe. Extra wide fit. Water-resistant leather upper. Soft padded collar. Padded dust tongue. Breathable textile lining. Ultra comfortable removable insole, antistatic, with a moisture control system creating a superior foot climate and improved comfort. Smooth-running, dirt-resistant lacing system. uvex 3D hydroflex foam insole for exceptional shock absorption in the heel and under the front of the foot. Dual-density PUR outdoor sole with integrated heel support and protection. Especially chunky, self-cleaning 4.5 mm tread with excellent grip and support in the arch area when climbing. Foamed scuffcap to protect the leather upper. Steel midsole. Sizes: 6-12. EN ISO 20345:2011 S3 SRC

Manufacturer Details

Manufacturer uvex
Manufacturer Code 8400.2

No videos available for this product

Reviews for this product

3 of 3 news itemsRelated news for this product

Posted on 14/07/2020European Commission classifies COVID-19 as risk 3 biological agent Read more

MEPs and the European Commission have confirmed that the COVID-19 virus is classed as a risk 3 group biological agent. This influences the level of safety measures that employers must follow.   ... Read more


Posted on 16/06/2020Two in five employees will refuse to work if given inadequate PPE Read more

A survey by Populus Data Solutions found that 40% of workers would refuse to return to work if they were not given adequate PPE. In a poll of over 2,000 workers and their attitudes to protective... Read more


Posted on 12/06/2020Building health and safety rating scheme tackles COVID-19 Read more

The International WELL Building Institute (IWBI) has launched a WELL Health-Safety rating scheme for buildings. This is the outcome of research into the response needed to tackle the COVID-19 pandemic... Read more


Login to start product discussions Discussions for this product